• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,775.74 -1,092.06
( -1.44%)
Global Indices
Nasdaq
50,682.40 17.12
(0.03%)
Dow Jones
7,583.98 42.62
(0.57%)
Hang Seng
66,385.32 1,692.20
(2.62%)
Nikkei 225
10,432.70 -72.31
(-0.69%)
Forex
USD-INR
95.78 0.20
(0.21%)
EUR-INR
111.44 0.28
(0.25%)
GBP-INR
128.72 0.02
(0.02%)
JPY-INR
0.60 0.00
(0.08%)

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530019
INE700A01033
145.1556811
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JUBLPHARMA
0
15790.61
EPS(TTM)
Face Value()
Div & Yield %
1.97
1
0.5
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales70.3067.3066.30
Other Operating Income0.000.000.10
Other Income 0.500.4042.40
Total Income70.8067.70108.80
Total Expenditure 64.5055.1054.60
PBIDT6.3012.6054.20
Interest 0.900.902.50
PBDT5.4011.7051.70
Depreciation1.301.601.60
Tax0.201.801.40
Fringe Benefit Tax0.000.000.00
Deferred Tax-53.301.7055.10
Reported Profit After Tax57.206.60-6.40
Extra-ordinary Items -8.500.0041.60
Adjusted Profit After Extra-ordinary item65.706.60-48.00
EPS (Unit Curr.)3.590.42-0.40
EPS (Adj) (Unit Curr.)3.590.42-0.40
Calculated EPS (Unit Curr.)3.600.42-0.40
Calculated EPS (Adj) (Unit Curr.)3.600.42-0.40
Calculated EPS (Ann.) (Unit Curr.)14.391.66-1.61
Calculated EPS (Adj) (Ann.) (Unit Curr.)14.391.66-1.61
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity15.9015.9015.90
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)8.9618.7281.75
PBDTM(%)7.6817.3877.98
PATM(%)81.379.81-9.65